Promoting healing

Promoting healing is a complex biological process involving the restoration of anatomical continuity and function to injured tissues (StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK470443/). It is not a specific molecular target, such as a receptor, enzyme, or transporter, but rather a therapeutic outcome or physiological phenomenon (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722805/). The process is traditionally divided into four overlapping stages: hemostasis, inflammation, proliferation, and remodeling (StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK470443/). In a clinical and pharmacological context, drugs that promote healing do so by modulating specific molecular entities like Platelet-Derived Growth Factor (PDGF) or Vascular Endothelial Growth Factor (VEGF) (PubMed, https://pubmed.ncbi.nlm.nih.gov/24441062/). Because it represents a multi-faceted cascade of events and cellular interactions rather than a single gene product, it is classified as an incorrect term for a canonical drug target. Successful therapeutic strategies in this area focus on optimizing the wound environment or stimulating specific regenerative pathways to treat chronic conditions like diabetic ulcers or pressure sores (NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722805/).

Other names

Wound healingTissue repairRegenerationCicatrization

Not applicable; this refers to a physiological process and therapeutic goal rather than a specific molecular mechanism of drug action.